Many experimental and associative studies indicate decreased insulin activity In specific regions of brain as a potential contributor to Alzheimer's disease (AD) and perhaps related neurodegenerative diseases. Importantly, recent pilot clinical trials have concluded that augmenting central nervous system (CNS) insulin activity improves or protects cognitive function in patients with amnestic Mild Cognitive Impairment (aMCl) or mild AD, perhaps especially patients without an e4 allele of the apolipoprotein E gene {APOE). We hypothesize that specific insulin-induced changes in the human cerebrospinal fluid (CSF) proteome will illuminate a set of biomarkers responsive to alterations In CNS Insulin activity. We will this hypothesis by achieving the following specific aims: (i) discover, confirm, and validate a novel """"""""CNS Insulin-Responsive Multi-Analyte Profile (MAP)"""""""" of specific changes In the CSF proteome with Increased CNS insulin activity using samples from two placebo-controlled randomized trials of intranasal insulin in patients with aMCI/mild AD, including Project 2, (ii) determine the significance of decreased CNS insulin activity In age-related cognitive decline, pre-clinical AD, and related diseases using our CNS Insulin-Responsive MAP, CSF samples and cognitive testing data from our Clinical Core and collaborative UWADRC CSF Bank, and established AD CSF biomarkers from our Neuropathology and Targeted Molecular Testing (NP&TMT) Core, and (iii) quantify brain regional concentration and cellular distribution of selected proteins from our CNS Insulin-Responsive MAP in a large series of autopsies from Controls and patients with AD who did or did not have diabetes mellitus (DM) whose tissue already is in the NP&TMT Core. When successfully completed, our proposed studies will have generated new knowledge about the mechanisms of action of increased CNS insulin activity in patients with aMCI/mild AD receiving insulin therapy, inversely determined the functional significance and specificity of decreased CNS insulin activity In age-related cognitive decline, preclinical AD, and related neurodegenerative diseases, and explored the regional and cellular distribution of selected key protein candidates in a well-characterized autopsy series of AD patients and controls with and without DM.

Public Health Relevance

AD is a looming public health disaster for US citizens, both patients and caregivers, and our health care system. There is no effective treatment for AD. This application is a direct response to the therapeutic imperative for AD, it is highly translational, and it draws on existing NIH-funded resources.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005136-30
Application #
8459477
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
30
Fiscal Year
2013
Total Cost
$176,829
Indirect Cost
$63,478
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Kunji, Khalid; Ullah, Ehsan; Nato Jr, Alejandro Q et al. (2018) GIGI-Quick: a fast approach to impute missing genotypes in genome-wide association family data. Bioinformatics 34:1591-1593
Taylor, Laura M; McMillan, Pamela J; Liachko, Nicole F et al. (2018) Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration. Mol Neurodegener 13:7
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Flanagan, Margaret E; Larson, Eric B; Walker, Rod L et al. (2018) Associations between Use of Specific Analgesics and Concentrations of Amyloid-? 42 or Phospho-Tau in Regions of Human Cerebral Cortex. J Alzheimers Dis 61:653-662
Tulloch, Jessica; Leong, Lesley; Thomson, Zachary et al. (2018) Glia-specific APOE epigenetic changes in the Alzheimer's disease brain. Brain Res 1698:179-186
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71

Showing the most recent 10 out of 753 publications